Your browser doesn't support javascript.
loading
Correlation between serum isoniazid concentration and therapeutic response in patients of pulmonary tuberculosis in Central India: A prospective observational study.
Ponmani, P; Jhaj, Ratinder; Shukla, Ajay Kumar; Khurana, Alkesh Kumar; Pathak, Prashant.
Afiliação
  • Ponmani P; Department of Pharmacology, All India Institute of Medical Sciences Bhopal, India. Electronic address: ponmani.p@manipal.edu.
  • Jhaj R; Department of Pharmacology, All India Institute of Medical Sciences Bhopal, India.
  • Shukla AK; Department of Pharmacology, All India Institute of Medical Sciences Bhopal, India.
  • Khurana AK; Department of Pulmonary Medicine, All India Institute of Medical Sciences, Bhopal, India.
  • Pathak P; DOTS Center, All India Institute of Medical Sciences, Bhopal, India.
Indian J Tuberc ; 71(2): 153-162, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38589119
ABSTRACT

BACKGROUND:

Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis is one of the top ten causes of death worldwide. Isoniazid (INH) is an important component of anti-tuberculosis therapy (ATT). Low isoniazid levels can serve as a risk factor for the development of treatment failure, relapse of disease and acquired secondary resistance. Hence, serum level of isoniazid becomes a critical factor in determining the treatment outcome of patients on ATT. This study aimed to evaluate the correlation between serum isoniazid concentration and therapeutic response in patients of pulmonary tuberculosis in Central India.

METHODS:

This was a prospective single cohort observational study conducted at a tertiary care hospital. Therapeutic response in newly diagnosed patients of pulmonary TB was determined based the microbiological, clinical and radiological parameters. Serum INH levels were estimated based on a spectrophotometric method using nano-spectrophotometer.

RESULTS:

In this study, patients had a significant improvement in treatment outcome as evident by a significant decrease in the TB score I at end of IP (p = 0.001) and a significant decline in the Timika score at end of CP (p = 0.001). Although all patients converted to sputum negative at end of CP, 20% remained positive at end of IP. Lower INH levels were seen in 13.3% of the study population. Higher INH levels were observed in sputum converters, patients with low TB score I and low Timika score, although no statistically significant difference was noted (p > 0.05).

CONCLUSION:

In this study, we could not find any statistically significant association between serum INH levels and therapeutic outcome of the patients. Further studies on a larger population could provide better understanding about the prevalence of low serum isoniazid levels among the Indian population and establish its relationship with therapeutic outcome. Also, the usage of a comparatively less expensive spectrophotometric method of analysis makes this feasible in almost every district hospital without the need of high-performance liquid chromatography which is costlier and needs more expertise.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Mycobacterium tuberculosis Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Mycobacterium tuberculosis Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article